Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 395,533 | 388,202 | 581,906 | 393,026 | 410,280 |
| Income taxes - deferred | -30,760 | -6,054 | 96,684 | -29,410 | 73,101 |
| Accounts receivable | 271,969 | -480,524 | 53,122 | 74,062 | 199,159 |
| Accounts payable and accrued liabilities | 30,675 | -105,292 | -113,267 | 77,272 | 1,311,586 |
| Other Working Capital | 391,033 | -389,057 | -130,726 | 45,634 | 1,422,486 |
| Other Operating Activity | -137,328 | 800,373 | 96,466 | 185,069 | -1,097,361 |
| Operating Cash Flow | $921,122 | $207,648 | $584,185 | $745,653 | $2,319,251 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -201,249 | -178,925 | -300,921 | -238,859 | -216,092 |
| Net Acquisitions | -22,178 | -104,648 | -101,931 | -46,147 | -64,499 |
| Purchase Of Investment | -51,578 | -10,739 | -66,255 | N/A | N/A |
| Sale Of Investment | 25,880 | 70,259 | 14,759 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -2,664 | 0 |
| Investing Cash Flow | $-249,125 | $-224,053 | $-454,348 | $-287,670 | $-280,591 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 243,396 | 1,059,332 | -314,241 | -487,080 | -1,151,862 |
| Debt Issued | 1,220,413 | 9,693 | 11,633 | 845,049 | 1,251,559 |
| Debt Repayment | -1,332,447 | -1,057,608 | -221,446 | -650,184 | -673,270 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | -149,865 |
| Dividend Paid | N/A | N/A | 0 | -351,170 | N/A |
| Other Financing Activity | -473,766 | -47,332 | -44,534 | -49,754 | -800,176 |
| Financing Cash Flow | $-342,404 | $-35,915 | $-568,588 | $-693,139 | $-1,523,614 |
| Exchange Rate Effect | 4,887 | 44,259 | -78,369 | -55,618 | -30,665 |
| Beginning Cash Position | 1,073,478 | 1,081,539 | 1,598,659 | 1,889,433 | 1,405,052 |
| End Cash Position | 1,407,958 | 1,073,478 | 1,081,539 | 1,598,659 | 1,889,433 |
| Net Cash Flow | $329,593 | $-52,320 | $-438,751 | $-235,156 | $515,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | 921,122 | 207,648 | 584,185 | 745,653 | 2,319,251 |
| Capital Expenditure | -209,357 | -184,301 | -306,374 | -245,441 | -218,191 |
| Free Cash Flow | 711,765 | 23,347 | 277,811 | 500,212 | 2,101,060 |